R.W.M has served as a consultant for Genmab/AbbVie, Adaptive Biotechnologies, Bristol-Myers Squibb, Intellia and Epizyme and received research funding (institutional) from Merck, Bristol-Myers Squibb, Genentech/Roche and Genmab. P.A. has served as a consultant for Merck, Bristol-Myers Squibb, Pfizer, Affimed, Adaptive, Infinity, ADC Therapeutics, Celgene and MorphoSys; received research funding (institutional) from Merck, Bristol-Myers Squibb, Affimed, Adaptive, Roche, Tensha, Otsuka, Sigma-Tau, Genentech and IGM; and received honoraria from Bristol-Myers Squibb and Merck. C.A.J. has served as a consultant for Kite, Novartis, Pfizer, Humanigen, Precision Bioscience, Bayer and Celgene and has received research funding from Pfizer and Kite.